OREANDA-NEWS. Banco Bradesco (NYSE: BBD; BBDO; Latibex: XBBDC and BM&FBOVESPA: BBDC3, BBDC4) informs its shareholders, clients, employees and the market that:

1. Its indirect subsidiary Bradesco Saude S.A. (Bradesco Saude), holder of 43.5% of the total voting capital stock of Odontoprev S.A. (Odontoprev), signed, on this date, with Mr. Randal Luiz Zanetti (Mr. Randal), agreement that establishes the terms and conditions of a reorganization of their respective stakes in Odontoprev (Reorganization), which will result in the indirect acquisition, by Bradesco Saude, and in the sale by Mr. Randal, of a stake representing 6.5% of the voting capital stock of Odontoprev;

2. After the acquisition, Bradesco Saude will hold approximately 50.01% of Odontoprev. In the context of Reorganization, Mr. Randal will hold a position on the Board of Executive Officers of Bradesco Seguros S.A.;

3. The operation is subject to the approval of Central Bank of Brazil; and

4. The Parties relied on the financial advice exclusive of Banco Bradesco BBI S.A.